2610002M06Rik Activators
Chemical activators of "2610002M06Rik" facilitate its functional enhancement through intricate biochemical mechanisms. Forskolin, by increasing intracellular cAMP, and Ionomycin, by elevating calcium levels, both converge on the activation of protein kinase A and other calcium-dependent kinases. These kinases are poised to phosphorylate and enhance the activity of "2610002M06Rik," assuming it is a substrate for these kinases or is otherwise positively regulated by them. This indirect activation route is shared by Phorbol 12-myristate 13-acetate (PMA), which activates PKC, another potential kinase that could phosphorylate "2610002M06Rik." Furthermore, Epigallocatechin gallate and Genistein selectively inhibit competitive kinase pathways, potentially alleviating the phosphorylation-driven inhibition of "2610002M06Rik," thereby promoting its activity.
The modulation of MAPK signaling by U0126 and SB203580, which inhibit MEK and p38 MAPK, respectively, can also indirectly facilitate the activation of "2610002M06Rik" by dampening negative feedback loops or deactivating competitive pathways. The specific inhibition of tyrosine kinases by Genistein may reduce phosphorylation that typically downregulates "2610002M06Rik," thus allowing the protein's activity to be more pronounced. The actions of A23187 and Thapsigargin, which increase intracellular calcium, activate calcium-dependent signaling pathways that may potentially phosphorylate and activate "2610002M06Rik." Collectively, these diverse yet specific chemical activators orchestrate a symphony of cellular signals that culminate in the enhanced functional activity of "2610002M06Rik," exemplifying the intricate nature of intracellular signaling and its capacity for fine-tuned regulation of protein function.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
This polyphenol inhibits multiple kinase pathways, which may result in the selective activation of "2610002M06Rik" by reducing competitive kinase activity that would otherwise phosphorylate and deactivate "2610002M06Rik." | ||||||
Ionomycin, free acid | 56092-81-0 | sc-263405 sc-263405A | 1 mg 5 mg | $96.00 $264.00 | 2 | |
Ionomycin acts as a calcium ionophore, raising intracellular calcium levels, which could activate calcium-dependent protein kinases that phosphorylate and enhance "2610002M06Rik" activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that when inhibiting PI3K/AKT pathway, could shift the balance of intracellular signaling towards pathways that activate "2610002M06Rik," if it is regulated by or associated with this pathway. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
S1P binds to its receptors, initiating a signaling cascade that can lead to the activation of MAPK and other kinases that could phosphorylate and thereby enhance "2610002M06Rik" activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is an activator of protein kinase C (PKC), which may phosphorylate and enhance "2610002M06Rik" if it is a substrate for PKC or if PKC activation leads to downstream signaling pathways that activate "2610002M06Rik." | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A calcium ionophore that increases intracellular calcium levels, potentially activating calcium-dependent kinases that could phosphorylate and activate "2610002M06Rik." | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
This inhibitor of p38 MAPK could deactivate negative feedback loops or competitive pathways, thereby enhancing pathways that lead to the activation of "2610002M06Rik." | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
As an inhibitor of PI3K, Wortmannin could shift intracellular signaling towards activation of alternative pathways, potentially leading to the activation of "2610002M06Rik." | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
As a tyrosine kinase inhibitor, Genistein may lead to the activation of "2610002M06Rik" by reducing phosphorylation events that would otherwise inactivate "2610002M06Rik" or by enhancing signaling through compensatory pathways. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a SERCA pump inhibitor, raising cytosolic calcium levels, which can activate calcium-dependent signaling pathways and potentially enhance "2610002M06Rik" activity if it is regulated by such pathways. | ||||||